Another promising molecular target for the detection of PCa is the gastrin-releasing peptide receptor (GRPR), a 7-trans-membrane G-protein-coupled receptor activating phospholipase C-signalling, which has been shown to be overexpressed especially in breast and prostate cancer [6–8]. Here, GRPR is linked to prostate cancer.